Directly from the paper covered by the post earlier, 90 year old equivalent mouse before and after treatment with FOXO4 D reverso inversio peptide, a FOXO4 inhibitor that blocks FOXO4 from arresting senescent cell apoptosis. Senolytics against Aging: Snapshot of a Fast Moving Field Josh Mitteldorf Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
foxo4-dri senolytic human trial What are the recommended dosing regimens, safety monitoring, and clinical trial considerations for senolytic agents such as dasatinib + quercetin, navitoclax, fisetin, and FOXO4‑DRI?